Copyright
        ©2011 Baishideng Publishing Group Co.
    
    
        World J Gastroenterol. May 21, 2011; 17(19): 2389-2396
Published online May 21, 2011. doi: 10.3748/wjg.v17.i19.2389
Published online May 21, 2011. doi: 10.3748/wjg.v17.i19.2389
            Table 1 Primers and fluorescent probe for human CXC chemokine receptor-4, stromal cell-derived factor-1 and GAPDH
        
    | Primers | 5'-3' | Product (bp) | 
| CXCR4 | Forward: TGGCCTTATCCTGCCTGGTAT | 173 | 
| Reverse: GGAGTCGATGCTGATCCCAAT | ||
| Taqman: AGAAGCGCAAGGCCCTCAAGACCA | ||
| SDF-1 | Forward: GAGCCAACGTCAAGCATCTCA | 103 | 
| Reverse: TTCGGGTCAATGCACACTTGT | ||
| Taqman: CTGTGCCCTTCAGATTGTAGCCCGG | ||
| GAPDH | Forward: TCATGGGTGTGAACCATGAGAA | 146 | 
| Reverse: GGCATGGACTGTGGTCATGAG | ||
| Taqman: TCATCAGCAATGCCTCCTGCACCA | 
            Table 2 Expression of CXC chemokine receptor-4 in primary gastric carcinoma and normal mucous membrane (mean ± SE)
        
    | Tissues | No. | CXCR4-mRNA | t | P | 
| Gastric cancer | 40 | 1.6244 ± 1.3801 | 2.554 | 0.015 | 
| Normal mucous membrane | 40 | 1.0715 ± 0.5243 | 
            Table 3 Expression of CXC chemokine receptor-4 in primary gastric carcinoma with or without lymph nodes metastasis (mean ± SE)
        
    | Lymph node metastasis | No. | CXCR4-mRNA | t | P | 
| Present | 32 | 0.823 ± 0.551 | 2.101 | 0.042 | 
| Absent | 8 | 0.392 ± 0.338 | 
            Table 4 Relationship between CXC chemokine receptor-4 expression and clinicopathological features in gastric cancer
        
    | Clinicopathologic parameters | No. | CXC chemokine receptor-4 | |||
| Positive | Negative | χ2 | P value | ||
| Sex | |||||
| Male | 31 | 18 | 13 | 0.006 | 0.9382 | 
| Female | 9 | 6 | 3 | ||
| Age (yr) | |||||
| > 56 | 19 | 12 | 7 | 0.007 | 0.9351 | 
| ≤ 56 | 21 | 13 | 8 | ||
| Tumor size (cm) | |||||
| ≥ 5 | 25 | 16 | 9 | 0.064 | 0.8001 | 
| < 5 | 15 | 9 | 6 | ||
| Tumor location | |||||
| Cardia of stomach | 2 | 2 | 0 | - | 0.8113 | 
| Fundus of stomach | 1 | 1 | 0 | ||
| Body of stomach | 6 | 4 | 2 | ||
| Antrum of stomach | 31 | 18 | 13 | ||
| Differentiation | |||||
| Moderate/well | 6 | 1 | 5 | - | 0.0213 | 
| Poor | 34 | 24 | 10 | ||
| Lymph node metastasis | |||||
| Present | 32 | 26 | 6 | 4.146 | 0.0422 | 
| Absent | 8 | 3 | 5 | ||
| Stage | |||||
| II and IIIa | 23 | 8 | 15 | 5.013 | 0.0251 | 
| IIIb and IV | 17 | 12 | 5 | ||
            Table 5 Expression of stromal cell-derived factor-1 in lymph nodes with or without gastric cancer cell metastasis (mean ± SE)
        
    | Lymph node metastasis | No. | SDF-1-mRNA | t | P | 
| With | 24 | 0.5432 ± 0.4907 | 2.338 | 0.025 | 
| Without | 16 | 0.2640 ± 0.2601 | 
- Citation: Zhao BC, Wang ZJ, Mao WZ, Ma HC, Han JG, Zhao B, Xu HM. CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma. World J Gastroenterol 2011; 17(19): 2389-2396
 - URL: https://www.wjgnet.com/1007-9327/full/v17/i19/2389.htm
 - DOI: https://dx.doi.org/10.3748/wjg.v17.i19.2389
 
